SPI Pharma

Wilmington, DE and Harleysville, PA | October 1, 2026 SPI Pharma, a global leader in pharmaceutical excipients, antacid actives, and...

WILMINGTON, DE — SEPTEMBER 29, 2026 SPI Pharma, a global developer of excipients, drug delivery technologies, vaccine adjuvants, and antacid...

Abstract The most relevant challenge concerning the semi-solid extrusion 3D printing (SSE) pharmaceutical application is the development of versatile inks...

Wilmington, Delaware - September 2026 SPI Pharma  announced that its strategic manufacturing partner, Q-Vant, has successfully achieved EXCiPACT certification, an...

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

FROM CHALLENGE TO TRIUMPH Formulating a 500 mg chewable Vitamin C tablet proved especially difficult due to the ingredient’s poor...

FROM CHALLENGE TO TRIUMPH Effervescent tablets pose unique formulation challenges — balancing tablet strength, dissolution, and appearance while managing large...

FROM CHALLENGE TO TRIUMPH Probiotics are highly sensitive to mechanical stress and moisture, making them difficult to formulate into direct...

Lubripharm™ SSF Our Sodium Stearyl Fumarate (SSF) excipients are backed by global regulatory audit approvals and designed to outperform traditional...

FROM CHALLENGE TO TRIUMPH Formulating a 300 mg tablet of micronized Tenofovir Disoproxil Fumarate (TDF) posed significant challenges due to...